is unclear; 4) these preparations may have unforeseeable adverse effects; 5) the availability of high quality preparations is unclear; and 6) resource impact (ie, costs) is unknown. Release and implementation of the recommendations. See online supplementary file S2, on the Arthritis & Rheumatology web site at http://onlinelibrary Cost implications and conflicts of interest. Cost implications are outside the scope of these recommendations. None of the panel members disclosed any conflict of